EMSY links breast cancer gene 2 to the 'Royal Family'

Breast Cancer Research

Volumn 6, Issue 5, 2004, Pages 201-203

  Yao, Jun ^a   Polyak, Kornelia ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

BRCA2; Breast cancer; EMSY; Familiar; Sporadic

Indexed keywords

BRCA2 PROTEIN; ONCOPROTEIN; PROTEIN EMSY; UNCLASSIFIED DRUG;

BREAST CANCER; CHROMATIN STRUCTURE; GENE FUNCTION; GENETIC LINKAGE; HUMAN; NOTE; ONCOGENE; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; GENES, BRCA2; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; REPRESSOR PROTEINS;

EID: 4544307746     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr916     Document Type: Note

References (27)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
2. Wooster R, Stratton MR: Breast cancer susceptibility: a complex disease unravels. Trends Genet 1995, 11:3-5.
3. Hofmann W, Schlag PM: BRCA1 and BRCA2 - breast cancer susceptibility genes. J Cancer Res Clin Oncol 2000, 126:487-496.
4. Paakkonen K, Sauramo S, Sarantaus L, Vahteristo P, Hartikainen A, Vehmanen P, Ignatius J, Ollikainen V, Kaariainen H, Vauramo E, et al.: Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population. Genet Epidemiol 2001, 20: 239-246.
5. Gayther SA, Pharoah PD, Ponder BA: The genetics of inherited breast cancer. J Mammary Gland Biol Neoplasia 1998, 3:365-376.
6. Dobrovic A, Simpfendorfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 1997, 57:3347-3350.
7. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, et al.: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 1999, 21:236-240.
8. Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, et al.: EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003, 115:523-535.
9. Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002, 108:171-182.
10. Powell SN, Kachnic LA: Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 2003, 22:5784-5791.
11. Jasin M: Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 2002, 21:8981-8993.
12. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997, 88:265-275.
13. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 1997, 386:804-810.
14. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX: Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 1999, 3:389-395.
15. Yuan SS, Lee SY, Chen G, Song M, Tomlinson GE, Lee EY: BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res 1999, 59:3547-3551.
16. Chapman MS, Verma IM: Transcriptional activation by BRCA1. Nature 1996, 382:678-679.
17. Monteiro AN, August A, Hanafusa H: Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 1996, 93:13595-13599.
18. Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T: Transcriptional activation functions in BRCA2. Nature 1997, 386:772-773.
19. Shin S, Verma IM: BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. Proc Natl Acad Sci USA 2003, 100:7201-7206.
20. Nordling M, Karlsson P, Wahlstrom J, Engwall Y, Wallgren A, Martinsson T: A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res 1998, 58:1372-1375.
21. Pilch DR, Sedelnikova OA, Redon C, Celeste A, Nussenzweig A, Bonner WM: Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem Cell Biol 2003, 81:123-129.
22. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997, 90:425-435.
23. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP: The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 2003, 28:69-74.
24. Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R: BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 2000, 102:257-265.
25. Marmorstein LY, Kinev AV, Chan GK, Bochar DA, Beniya H, Epstein JA, Yen TJ, Shiekhattar R: A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell 2001, 104:247-257.
26. Bekri S, Adelaide J, Merscher S, Grosgeorge J, Caroli-Bosc F, Perucca-Lostanlen D, Kelley PM, Pebusque MJ, Theillet C, Birnbaum D, Gaudray P: Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet Cell Genet 1997, 79:125-131.
27. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL: Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 2003, 78:323-335.